IE69861B1 - NADH and MADPH as energy substitutes - Google Patents

NADH and MADPH as energy substitutes

Info

Publication number
IE69861B1
IE69861B1 IE920198A IE920198A IE69861B1 IE 69861 B1 IE69861 B1 IE 69861B1 IE 920198 A IE920198 A IE 920198A IE 920198 A IE920198 A IE 920198A IE 69861 B1 IE69861 B1 IE 69861B1
Authority
IE
Ireland
Prior art keywords
nadh
adenine dinucleotide
reduced form
nadph
nicotinamide adenine
Prior art date
Application number
IE920198A
Other languages
English (en)
Other versions
IE920198A1 (en
Inventor
Joerg Birkmayer
Walter Birkmayer
Original Assignee
Joerg Birkmayer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joerg Birkmayer filed Critical Joerg Birkmayer
Publication of IE920198A1 publication Critical patent/IE920198A1/en
Publication of IE69861B1 publication Critical patent/IE69861B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Dental Preparations (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE920198A 1991-01-24 1992-01-23 NADH and MADPH as energy substitutes IE69861B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4102240A DE4102240C1 (enExample) 1991-01-24 1991-01-24

Publications (2)

Publication Number Publication Date
IE920198A1 IE920198A1 (en) 1992-07-29
IE69861B1 true IE69861B1 (en) 1996-10-16

Family

ID=6423720

Family Applications (1)

Application Number Title Priority Date Filing Date
IE920198A IE69861B1 (en) 1991-01-24 1992-01-23 NADH and MADPH as energy substitutes

Country Status (14)

Country Link
EP (1) EP0496479B1 (enExample)
JP (1) JP2533709B2 (enExample)
AT (1) ATE112664T1 (enExample)
AU (1) AU663479B2 (enExample)
BR (1) BR9200207A (enExample)
CA (1) CA2059510C (enExample)
DE (2) DE4102240C1 (enExample)
DK (1) DK0496479T3 (enExample)
ES (1) ES2061313T3 (enExample)
FI (1) FI920323A7 (enExample)
HU (1) HU9200213D0 (enExample)
IE (1) IE69861B1 (enExample)
NO (1) NO304672B1 (enExample)
ZA (1) ZA92275B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735293A1 (en) * 1995-01-17 1996-07-18 Menuco Corp. Nadh and nadph therapeutic agents for dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
IT1318565B1 (it) * 2000-06-09 2003-08-27 World Pharma Tech Ltd Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e.
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose
DE102008010245B4 (de) * 2008-02-20 2011-02-10 Emag Holding Gmbh Verfahren zum Schleifen wellenförmiger Werkstücke
DE102014103443A1 (de) * 2014-03-13 2015-09-17 Jürgen Ruhlmann Komposition zur Verwendung zur Behandlung von Müdigkeit, Konzentrationsschwäche, Entzugserscheinungen, Kopfschmerzen und Erkältungskrankheiten, insbesondere Leistungsabfall, Kater und Müdigkeit
WO2020021734A1 (ja) * 2018-07-26 2020-01-30 オリジンバイオテクノロジー株式会社 機能性鶏卵及びその生産方法
DE202022000567U1 (de) 2022-03-06 2022-03-16 Penta Phi Eg Liposomale Formulierung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594475A (en) * 1968-04-24 1971-07-20 Kyowa Hakko Kogyo Kk Method of treating and preventing the side effects of antibiotics
DE3380342D1 (en) * 1982-10-26 1989-09-14 Cta Finanz Ag Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals
IT1162938B (it) * 1983-08-26 1987-04-01 Dino Spisni Composizione per la cura dei tumori maligni in particolare sugli animali
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
DE58905201D1 (de) * 1988-03-01 1993-09-16 Birkmayer Walther Mittel zur behandlung des parkinson-syndroms.
AT397201B (de) * 1988-06-03 1994-02-25 Birkmayer Joerg Ddr Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels

Also Published As

Publication number Publication date
DE4102240C1 (enExample) 1992-04-09
FI920323L (fi) 1992-07-25
ZA92275B (en) 1992-12-30
NO920315D0 (no) 1992-01-23
FI920323A0 (fi) 1992-01-24
DE59200603D1 (de) 1994-11-17
AU663479B2 (en) 1995-10-12
FI920323A7 (fi) 1992-07-25
NO304672B1 (no) 1999-02-01
JP2533709B2 (ja) 1996-09-11
CA2059510A1 (en) 1992-07-25
AU1039292A (en) 1992-07-30
BR9200207A (pt) 1992-10-06
ATE112664T1 (de) 1994-10-15
DK0496479T3 (da) 1995-04-18
EP0496479B1 (de) 1994-10-12
JPH05262652A (ja) 1993-10-12
NO920315L (no) 1992-07-27
CA2059510C (en) 1997-06-10
EP0496479A1 (de) 1992-07-29
IE920198A1 (en) 1992-07-29
ES2061313T3 (es) 1994-12-01
HU9200213D0 (en) 1992-04-28

Similar Documents

Publication Publication Date Title
Westerfeld et al. Metabolism and caloric value of alcohol
US7115285B2 (en) Composition and method for appetite and craving suppression and mood enhancement
USRE43029E1 (en) Process for preparing a creatine heterocyclic acid salt and method of use
KR101444497B1 (ko) 안드로그라폴라이드를 유효 성분으로 하는 항피로제 및 경구 조성물
US20050271739A1 (en) Methods and compositions for accelerating alcohol metabolism
WO2010021766A1 (en) Hydroxybutyrate ester and medical use thereof
KR101528381B1 (ko) 세사민류와 비타민 ｂ１ 류를 배합한 조성물
IE69861B1 (en) NADH and MADPH as energy substitutes
CA2434482C (en) Food supplement with a slimming effect
AU782479B2 (en) Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract
US20100015259A1 (en) Composition and method for improving human concentration, memory and other cognitive brain
AU3442899A (en) Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
CN110801018A (zh) 辅酶q10维生素c运动含片
JPH0733653A (ja) アセトアルデヒド毒性の抑制剤
US6703371B1 (en) Preparations for reducing oxygen consumption during physical efforts
Elvehjem The biological significance of nicotinic acid: Harvey lecture, November 16, 1939
US5098719A (en) Food composition comprising urea
JP5601747B2 (ja) 疲労予防用内服用組成物及び疲労予防用内服用製剤
JP2008545766A (ja) （−）−エピガロカテキンガレートの新規使用
CN120514111A (zh) 一种营养组合物及其应用
Stevens Does Alcohol Afford Nutrition to the Animal Tissues?
JPH1160490A (ja) 肝機能調節剤
HUP0900671A2 (en) Process for producing powder tablet or beverage dissociation stimulaling of acetaldihid

Legal Events

Date Code Title Description
MM4A Patent lapsed